Thus, the role of MSU-42011 in reducing FOXP3+ Tregs and increasing activated CD8+ T cells in the MPNST model is particularly intriguing (Figure 2D,E), potentially alleviating immune suppression and enhancing anti-tumor immunity. The gene discussed is CD8A; the disease is malignant peripheral nerve sheath tumor.